Grants.gov · forecast:forecasted

Expanded Surveillance for Pediatric Infectious Diseases

  • Verified from source 1 day ago
  • Updated 24 days ago
  • Amendment detected
Agency
Centers for Disease Control and Prevention - ERA
Office
HHS-CDC-HHSCDCERA
Type
forecast:forecasted
Kind
grant
Posted
Jul 28, 2026
Place
Notice ID
363342
Source
Grants.gov
First seen
Sep 18, 2026, 1:21 PM UTC

Full scope

The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to support a network of U.S. institutions that will conduct standardized, prospective, active surveillance of pediatric acute respiratory illness (ARI) and acute gastroenteritis (AGE). The network will focus on respiratory and enteric viruses among pediatric patients seeking healthcare.

In addition, the network will generate robust estimates of the effectiveness of influenza, rotavirus, respiratory syncytial virus (RSV) and other prevention products against respiratory and enteric viral illnesses in this population.

Recipients will identify AGE and ARI illnesses among patients seeking healthcare or diagnostic testing for acute illness among inpatient and emergency department populations. Recipients may also include patients seeking care in outpatient clinics, such as urgent care centers, as an optional activity.

This is a multi-component NOFO. You must apply for ComponentA (Core Component). You may also apply for one or more optional components.

Component A – Core Component (Required)

Support inpatient and emergency department pediatric surveillance

Follow the standardized protocol established by CDC

Optional Components

Component B: Support outpatient pediatric surveillance

Component C: Study immune response and infection

Component D: Study immune response and immunization

Recipients will enroll patients meeting standard symptom criteria and confirm viral infections using approved molecular assays. The network will use the data to estimate prevention product effectiveness, hospitalization rates, and information on the natural history of medically attended diseases.

Findings of this NOFO will:

Improve best practices for diagnosis and treatment protocols

Inform prevention product recommendations

Guide public health strategies

Reduce viral illness-associated hospitalizations and healthcare utilization among children

Contacts

Full record synced 7 days ago from Grants.gov (forecast)